A Study Evaluating Physical Activity and Joint Health in Severe Haemophilia A Patients ≥12 Years Treated Once Weekly With Efanesoctocog Alfa
Clinical trial NCT05817812 · COMPLETED
Trial details
- NCT number
- NCT05817812
- Sponsor
- Swedish Orphan Biovitrum
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-31
- Primary completion
- 2026-06-02
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.